The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate Cancer

The progression of numerous malignancies has been linked to N6-methyladenosine (m6A) alteration. However, the opposite trend of m6A levels in the development and metastasis of cancer has not been reported. This study aimed to evaluate the biological function and mechanism of fat mass and obesity-ass...

Full description

Bibliographic Details
Main Authors: Yue Zhao, Xin Hu, Haoran Yu, Huimin Sun, Lei Zhang, Chen Shao
Format: Article
Language:English
Published: American Association for the Advancement of Science (AAAS) 2024-01-01
Series:Research
Online Access:https://spj.science.org/doi/10.34133/research.0313
_version_ 1827345861542150144
author Yue Zhao
Xin Hu
Haoran Yu
Huimin Sun
Lei Zhang
Chen Shao
author_facet Yue Zhao
Xin Hu
Haoran Yu
Huimin Sun
Lei Zhang
Chen Shao
author_sort Yue Zhao
collection DOAJ
description The progression of numerous malignancies has been linked to N6-methyladenosine (m6A) alteration. However, the opposite trend of m6A levels in the development and metastasis of cancer has not been reported. This study aimed to evaluate the biological function and mechanism of fat mass and obesity-associated protein (FTO) in regulating m6A modification in prostate cancer development and epithelial–mesenchymal transition (EMT). An EMT model of LNCaP and PC-3 cells was established with transforming growth factor-β treatment, and FTO knockout cell line was established in prostate cancer cells using the CRISPR/Cas9 gene editing technology. The level of m6A modification in tumor tissues was higher than that in normal prostate tissues; m6A levels were decreased after EMT. FTO deletion increased m6A expression and enhanced PC-3 cell motility, invasion, and EMT both in vitro and in vivo. RNA sequencing and functional investigations suggested that DDIT4, a novel EMT target gene, plays a role in m6A-regulated EMT, which was recognized and stabilized by the m6A effector IGF2BP2/3. Decreased FTO expression was an independent indicator of worse survival, and the level of DDIT4 was considerably elevated in patients with bone metastasis. Thus, this study revealed that the m6A demethylase FTO can play different roles in prostate cancer as a regulator of EMT and an inhibitor of m6A modification. Moreover, DDIT4 can be suggested as a possible biomarker for prostate cancer metastasis prediction.
first_indexed 2024-03-07T23:19:49Z
format Article
id doaj.art-4b9db0fc610a4ba98719a11a0f8effc6
institution Directory Open Access Journal
issn 2639-5274
language English
last_indexed 2024-03-07T23:19:49Z
publishDate 2024-01-01
publisher American Association for the Advancement of Science (AAAS)
record_format Article
series Research
spelling doaj.art-4b9db0fc610a4ba98719a11a0f8effc62024-02-21T08:19:19ZengAmerican Association for the Advancement of Science (AAAS)Research2639-52742024-01-01710.34133/research.0313The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate CancerYue Zhao0Xin Hu1Haoran Yu2Huimin Sun3Lei Zhang4Chen Shao5Department of Urology, Xiang’an Hospital of Xiamen University, Xiamen University, Xiamen, China.State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology, Harbin, China.State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology, Harbin, China.Department of Urology, Xiang’an Hospital of Xiamen University, Xiamen University, Xiamen, China.Department of Public healthy, Xiamen University, Xiamen, China.Department of Urology, Xiang’an Hospital of Xiamen University, Xiamen University, Xiamen, China.The progression of numerous malignancies has been linked to N6-methyladenosine (m6A) alteration. However, the opposite trend of m6A levels in the development and metastasis of cancer has not been reported. This study aimed to evaluate the biological function and mechanism of fat mass and obesity-associated protein (FTO) in regulating m6A modification in prostate cancer development and epithelial–mesenchymal transition (EMT). An EMT model of LNCaP and PC-3 cells was established with transforming growth factor-β treatment, and FTO knockout cell line was established in prostate cancer cells using the CRISPR/Cas9 gene editing technology. The level of m6A modification in tumor tissues was higher than that in normal prostate tissues; m6A levels were decreased after EMT. FTO deletion increased m6A expression and enhanced PC-3 cell motility, invasion, and EMT both in vitro and in vivo. RNA sequencing and functional investigations suggested that DDIT4, a novel EMT target gene, plays a role in m6A-regulated EMT, which was recognized and stabilized by the m6A effector IGF2BP2/3. Decreased FTO expression was an independent indicator of worse survival, and the level of DDIT4 was considerably elevated in patients with bone metastasis. Thus, this study revealed that the m6A demethylase FTO can play different roles in prostate cancer as a regulator of EMT and an inhibitor of m6A modification. Moreover, DDIT4 can be suggested as a possible biomarker for prostate cancer metastasis prediction.https://spj.science.org/doi/10.34133/research.0313
spellingShingle Yue Zhao
Xin Hu
Haoran Yu
Huimin Sun
Lei Zhang
Chen Shao
The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate Cancer
Research
title The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate Cancer
title_full The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate Cancer
title_fullStr The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate Cancer
title_full_unstemmed The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate Cancer
title_short The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate Cancer
title_sort fto mediated n6 methyladenosine modification of ddit4 regulation with tumorigenesis and metastasis in prostate cancer
url https://spj.science.org/doi/10.34133/research.0313
work_keys_str_mv AT yuezhao theftomediatedn6methyladenosinemodificationofddit4regulationwithtumorigenesisandmetastasisinprostatecancer
AT xinhu theftomediatedn6methyladenosinemodificationofddit4regulationwithtumorigenesisandmetastasisinprostatecancer
AT haoranyu theftomediatedn6methyladenosinemodificationofddit4regulationwithtumorigenesisandmetastasisinprostatecancer
AT huiminsun theftomediatedn6methyladenosinemodificationofddit4regulationwithtumorigenesisandmetastasisinprostatecancer
AT leizhang theftomediatedn6methyladenosinemodificationofddit4regulationwithtumorigenesisandmetastasisinprostatecancer
AT chenshao theftomediatedn6methyladenosinemodificationofddit4regulationwithtumorigenesisandmetastasisinprostatecancer
AT yuezhao ftomediatedn6methyladenosinemodificationofddit4regulationwithtumorigenesisandmetastasisinprostatecancer
AT xinhu ftomediatedn6methyladenosinemodificationofddit4regulationwithtumorigenesisandmetastasisinprostatecancer
AT haoranyu ftomediatedn6methyladenosinemodificationofddit4regulationwithtumorigenesisandmetastasisinprostatecancer
AT huiminsun ftomediatedn6methyladenosinemodificationofddit4regulationwithtumorigenesisandmetastasisinprostatecancer
AT leizhang ftomediatedn6methyladenosinemodificationofddit4regulationwithtumorigenesisandmetastasisinprostatecancer
AT chenshao ftomediatedn6methyladenosinemodificationofddit4regulationwithtumorigenesisandmetastasisinprostatecancer